HC Q meta analysis
See all studies
Early, Late
IHU Marseille (Preprint) (meta analysis - not included in study count)
Meta-analysis on ch loroquine derivatives and COVID-19 mortality
Updated meta analysis of 26 studies showing C Q/HC Q OR 0.60 [0.50 - 0.73], p<0.0001 from clinical studies.
For big data studies authors find inconsistent results and OR 0.84 [0.75 - 0.94], p=0.003.
Horby et al. excluded due to toxic doses, Skipper et al. excluded due to low PCR testing, Peters et al. excluded due to treatment being delayed until deterioration. Only a summary is provided. Different treatment delays (except Peters), risk level of patients, differences in dosage (except Horby), and usage of Zinc are not considered.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.